Literature DB >> 15529386

Exploring complement activation to develop biomarkers for systemic lupus erythematosus.

George C Tsokos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15529386     DOI： 10.1002/art.20602

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

1.  T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis.

Authors:  Robert A Cohen; George Bayliss; Jose C Crispin; Gwen F Kane-Wanger; Christine A Van Beek; Vasileios C Kyttaris; Ingrid Avalos; C Yung Yu; George C Tsokos; Isaac E Stillman
Journal:  Clin Immunol       Date:  2008-07       Impact factor: 3.969

2.  Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity.

Authors:  José C Crispín; Brendan T Keenan; Michele D Finnell; Bonnie L Bermas; Peter Schur; Elena Massarotti; Elizabeth W Karlson; Lisa M Fitzgerald; Sukran Ergin; Vasileios C Kyttaris; George C Tsokos; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2010-05

3.  Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis.

Authors:  Cristiane B Dias; Patrícia Malafronte; Jin Lee; Aline Resende; Lectícia Jorge; Cilene C Pinheiro; Denise Malheiros; Viktoria Woronik
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

4.  The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Authors:  D J Birmingham; F Irshaid; H N Nagaraja; X Zou; B P Tsao; H Wu; C Y Yu; L A Hebert; B H Rovin
Journal:  Lupus       Date:  2010-07-06       Impact factor: 2.911

5.  Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

Authors:  Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Daniel J Birmingham; Brad H Rovin
Journal:  Theor Biol Med Model       Date:  2010-05-17       Impact factor: 2.432

6.  Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator.

Authors:  Aniko Hever; Richard B Roth; Peter Hevezi; Maria E Marin; Jose A Acosta; Hector Acosta; Jose Rojas; Rosa Herrera; Dimitri Grigoriadis; Evan White; Paul J Conlon; Richard A Maki; Albert Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-17       Impact factor: 11.205

7.  Predictors of the start of declining eGFR in patients with systemic lupus erythematosus.

Authors:  Terry Cheuk-Fung Yip; Suchi Saria; Michelle Petri; Laurence S Magder
Journal:  Lupus       Date:  2020-10-28       Impact factor: 2.911

8.  Complement levels and risk of organ involvement in patients with systemic lupus erythematosus.

Authors:  Ignacio Javier Gandino; Marina Scolnik; Emmanuel Bertiller; Valeria Scaglioni; Luis Jose Catoggio; Enrique Roberto Soriano
Journal:  Lupus Sci Med       Date:  2017-06-25

9.  Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.

Authors:  Seung Jun Kim; Hyang Mo Koo; Beom Jin Lim; Hyung Jung Oh; Dong Eun Yoo; Dong Ho Shin; Mi Jung Lee; Fa Mee Doh; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Kyu Hun Choi; Hyeon Joo Jeong; Seung Hyeok Han
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.